CD8A and cancer: The regulatory mechanisms of Bifidobacteria in cancer immunotherapy involve three main aspects: In the tumor immune microenvironment, Bifidobacterium intestinalis promotes dendritic cell-dependent Th1 differentiation; enhances CD8+ T cell activity to modulate the immune response; and induces immune responses against microbial antigens that cross-react with tumor-associated antigens.